[1]
|
NUCLEOTIDE SEQUENCE [MRNA].
DOI=10.1093/nar/15.7.3178; PubMed=3562249 [NCBI, ExPASy, EBI, Israel, Japan]
Tanaka T.,
Kimura S.,
Ota Y.;
"Sequence of a cDNA coding for bovine pancreatic phospholipase A2.";
Nucleic Acids Res. 15:3178-3178(1987).
|
[2]
|
PROTEIN SEQUENCE OF 16-22.
TISSUE=Pancreas;
Dutilh C.E.,
van Doren P.J.,
Verheul F.E.A.M.,
de Haas G.H.;
"Isolation and properties of prophospholipase A2 from ox and sheep pancreas.";
Eur. J. Biochem. 53:91-97(1975).
|
[3]
|
PROTEIN SEQUENCE OF 23-145.
PubMed=620674 [NCBI, ExPASy, EBI, Israel, Japan]
Fleer E.A.M.,
Verheij H.M.,
de Haas G.H.;
"The primary structure of bovine pancreatic phospholipase A2.";
Eur. J. Biochem. 82:261-269(1978).
|
[4]
|
X-RAY CRYSTALLOGRAPHY (2.4 ANGSTROMS), AND DISULFIDE BONDS.
DOI=10.1016/0022-2836(78)90146-8; PubMed=712836 [NCBI, ExPASy, EBI, Israel, Japan]
Dijkstra B.W.,
Drenth J.,
Kalk K.H.,
Vandermaelen P.J.;
"Three-dimensional structure and disulfide bond connections in bovine pancreatic phospholipase A2.";
J. Mol. Biol. 124:53-60(1978).
|
[5]
|
X-RAY CRYSTALLOGRAPHY (1.7 ANGSTROMS), ACTIVE SITE, AND CATALYTIC MECHANISM.
DOI=10.1038/289604a0; PubMed=7464926 [NCBI, ExPASy, EBI, Israel, Japan]
Dijkstra B.W.,
Drenth J.,
Kalk K.H.;
"Active site and catalytic mechanism of phospholipase A2.";
Nature 289:604-606(1981).
|
[6]
|
X-RAY CRYSTALLOGRAPHY (1.7 ANGSTROMS).
DOI=10.1016/0022-2836(81)90081-4; PubMed=7265241 [NCBI, ExPASy, EBI, Israel, Japan]
Dijkstra B.W.,
Kalk K.H.,
Hol W.G.J.,
Drenth J.;
"Structure of bovine pancreatic phospholipase A2 at 1.7A resolution.";
J. Mol. Biol. 147:97-123(1981).
|
[7]
|
X-RAY CRYSTALLOGRAPHY (3.0 ANGSTROMS) OF PROENZYME.
Dijkstra B.W.,
van Nes G.J.H.,
Kalk K.H.,
Brandenburg N.P.,
Hol W.G.J.,
Drenth J.;
"The structure of bovine pancreatic prophospholipase A2 at 3.0-A resolution.";
Acta Crystallogr. B 38:793-799(1982).
|
[8]
|
X-RAY CRYSTALLOGRAPHY (1.72 ANGSTROMS).
DOI=10.1021/bi961576x; PubMed=9115986 [NCBI, ExPASy, EBI, Israel, Japan]
Sekar K.,
Yu B.Z.,
Rogers J.,
Lutton J.,
Liu X.,
Chen X.,
Tsai M.-D.,
Jain M.K.,
Sundaralingam M.;
"Phospholipase A2 engineering. Structural and functional roles of the highly conserved active site residue aspartate-99.";
Biochemistry 36:3104-3114(1997).
|
[9]
|
X-RAY CRYSTALLOGRAPHY (1.5 ANGSTROMS).
DOI=10.1021/bi971370b; PubMed=9369492 [NCBI, ExPASy, EBI, Israel, Japan]
Sekar K.,
Eswaramoorthy S.,
Jain M.K.,
Sundaralingam M.;
"Crystal structure of the complex of bovine pancreatic phospholipase A2 with the inhibitor 1-hexadecyl-3-(trifluoroethyl)-sn-glycero-2-phosphomethanol.";
Biochemistry 36:14186-14191(1997).
|
[10]
|
X-RAY CRYSTALLOGRAPHY (1.95 ANGSTROMS) OF MUTANTS.
DOI=10.1107/S0907444998013699; PubMed=10089353 [NCBI, ExPASy, EBI, Israel, Japan]
Sekar K.,
Biswas R.,
Li Y.,
Tsai M.,
Sundaralingam M.;
"Structures of the catalytic site mutants D99A and H48Q and the calcium-loop mutant D49E of phospholipase A2.";
Acta Crystallogr. D 55:443-447(1999).
|
[11]
|
STRUCTURE BY NMR.
DOI=10.1021/bi982211a; PubMed=10074343 [NCBI, ExPASy, EBI, Israel, Japan]
Yuan C.,
Byeon I.-J.L.,
Li Y.,
Tsai M.-D.;
"Structural analysis of phospholipase A2 from functional perspective. 1. Functionally relevant solution structure and roles of the hydrogen-bonding network.";
Biochemistry 38:2909-2918(1999).
|
[12]
|
STRUCTURE BY NMR OF MUTANTS.
DOI=10.1021/bi9822123; PubMed=10074344 [NCBI, ExPASy, EBI, Israel, Japan]
Yuan C.,
Byeon I.-J.L.,
Poi M.-J.,
Tsai M.-D.;
"Structural analysis of phospholipase A2 from functional perspective. 2. Characterization of a molten globule-like state induced by site-specific mutagenesis.";
Biochemistry 38:2919-2929(1999).
|
|
ExPASy Home page
SIB Switzerland
